Regencell Bioscience HoldingRGC
13F holders, Q3 2025 (September 30)16holders +2
7new positions
5sold out
$15.45avg. 13F price*
At the end of Q3 2025, 16 institutions reported holding Regencell Bioscience Holding (RGC) in their 13F filings, up 2 from Q2 2025. 7 opened new positions and 5 sold out. The largest holders were Geode Capital Management, LLC ($6.5M), Squarepoint Ops LLC ($792K) and Discovery Capital Management, LLC / CT ($713K).
- Company
- Regencell Bioscience Holding
- CUSIP
- G7487R100
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2025 → Q3 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 7 | $1.8M |
| Exits | 5 | $1.3M |
All 13F filers, Q2 2025 → Q3 2025: 148,294 shares bought and 206,201 shares sold, net −57,907 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 16 holders
| Geode Capital Management, LLC | 0.00% | Add +7.4% | 419,970 | $6.5M |
| Squarepoint Ops LLC | 0.00% | Reduce -48.7% | 51,249 | $792K |
| Discovery Capital Management, LLC / CT | 0.04% | New | 46,166 | $713K |
| XTX Topco Ltd | 0.03% | New | 38,735 | $598K |
| Morgan Stanley | 0.00% | Add +14.6% | 37,842 | $585K |
| Vident Advisory, LLC | 0.00% | New | 18,068 | $279K |
| Jane Street Group, LLC | 0.00% | New | 10,616 | $164K |
| BlackRock, Inc. | 0.00% | Reduce -43.4% | 4,865 | $75K |
| BNP Paribas Financial Markets | 0.00% | Reduce -89.6% | 4,682 | $72K |
| UBS Group AG | 0.00% | Reduce -99.0% | 380 | $6K |
| Tower Research Capital LLC (TRC) | 0.00% | New | 357 | $6K |
| Farther Finance Advisors, LLC | 0.00% | Add +544.0% | 322 | $5K |
| Osaic Holdings, Inc. | 0.00% | Add +19.5% | 227 | $3K |
| Simplex Trading, LLC | 0.00% | New | 217 | $3K |
| Group One Trading LLC | 0.00% | New | 100 | $2K |
| Bank of America Corp. | 0.00% | Reduce -85.0% | 15 | $232 |
"% of holder's portfolio" is RGC's weight in each manager's 13F, not the share of Regencell Bioscience Holding the manager owns.